Enlivex Therapeutics Ltd

NASDAQ:ENLV 4:00:00 PM EDT

1.54

-0.03 (-1.91%)

7:48:37 PM EDT: $1.56 +0.02 (+1.30%)

Enlivex Therapeutics Ltd Stock, NASDAQ:ENLV

14 Einstein Street, 14 Einstein Street, Ness Ziona, Tel Aviv 7403618

Israel

Phone: +972.8.662.3301

Number of Employees: 49

http://www.enlivex.com

Description

Enlivex Therapeutics Ltd. engages in the development of macrophage reprogramming immunotherapy products. It focuses on the development of Allocetra, a universal off-the-shelf cell therapy designed to reprogram macrophages into their homeostatic state. The company was founded by Dror Mevorach on January 22, 2012 and is headquartered in Ness Ziona, Israel.